US 11780845
FGFR inhibitors and methods of use thereof
granted A61PA61P35/00
Quick answer
US patent 11780845 (FGFR inhibitors and methods of use thereof) held by Relay Therapeutics, Inc. expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Relay Therapeutics, Inc.
- Grant date
- Tue Oct 10 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 2
- CPC classes
- A61P, A61P35/00